BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23103365)

  • 1. Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Shah C; Wilkinson JB; Lanni T; Jawad M; Wobb J; Fowler A; Wallace M; Chen P; Grills IS; Vicini F
    Clin Breast Cancer; 2013 Jun; 13(3):206-11. PubMed ID: 23103365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Chen PY; Wallace M; Mitchell C; Grills I; Kestin L; Fowler A; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):991-7. PubMed ID: 19515514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
    Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
    Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy.
    Berrang TS; Olivotto I; Kim DH; Nichol A; Cho BC; Mohamed IG; Parhar T; Wright JR; Truong P; Tyldesley S; Sussman J; Wai E; Whelan T
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1220-7. PubMed ID: 20971571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ.
    Shah C; McGee M; Wilkinson JB; Berry S; Grills I; Wallace M; Mitchell C; Vicini F
    Clin Breast Cancer; 2012 Aug; 12(4):259-63. PubMed ID: 22658839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.
    Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV
    Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy.
    Nichols EM; Feigenberg SJ; Marter K; Cheston SB; Lasio G; Tkaczuk K; Kesmodel S; Buras R; Regine WF
    Am J Clin Oncol; 2013 Jun; 36(3):232-8. PubMed ID: 22549267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
    Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.
    Horst KC; Fasola C; Ikeda D; Daniel B; Ognibene G; Goffinet DR; Dirbas FM
    Breast; 2016 Aug; 28():178-83. PubMed ID: 27322859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the number of cautionary and/or unsuitable risk factors on outcomes after accelerated partial breast irradiation.
    Wobb J; Wilkinson JB; Shah C; Mitchell C; Wallace M; Ye H; Stromberg J; Grills I; Chen PY
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):134-8. PubMed ID: 23920392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.
    Horst KC; Fero KE; Ikeda DM; Daniel BL; Dirbas FM
    Radiother Oncol; 2013 Aug; 108(2):220-5. PubMed ID: 23597699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.
    Wilkinson JB; Beitsch PD; Shah C; Arthur D; Haffty BG; Wazer DE; Keisch M; Shaitelman SF; Lyden M; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1179-85. PubMed ID: 23182700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.
    Leonardi MC; Maisonneuve P; Mastropasqua MG; Morra A; Lazzari R; Rotmensz N; Sangalli C; Luini A; Veronesi U; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):806-13. PubMed ID: 22245196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumpectomy closure technique does not affect dosimetry in patients undergoing external-beam-based accelerated partial breast irradiation.
    Shaikh T; Narra V; Goyal S; Ahlawat S; Kirstein L; Kearney T; Haffty BG; Khan AJ
    Ann Surg Oncol; 2013 Apr; 20(4):1323-8. PubMed ID: 23229200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.
    Olivotto IA; Whelan TJ; Parpia S; Kim DH; Berrang T; Truong PT; Kong I; Cochrane B; Nichol A; Roy I; Germain I; Akra M; Reed M; Fyles A; Trotter T; Perera F; Beckham W; Levine MN; Julian JA
    J Clin Oncol; 2013 Nov; 31(32):4038-45. PubMed ID: 23835717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation.
    Shah C; Wilkinson JB; Jawad M; Wobb J; Berry S; Mitchell C; Wallace M; Vicini FA
    Clin Breast Cancer; 2012 Dec; 12(6):392-7. PubMed ID: 23063380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.